Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.41 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 6/20 | 0.40 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.40 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18364377 | 0.98 | HCAR2 (0.47) | ATMHCAR2EPHX2MAPTRAB9A | |
| SCHEMBL18364364 | 0.98 | HCAR2 (0.47) | ATMHCAR2EPHX2MAPTRAB9A | |
| SCHEMBL18364383 | 0.95 | ATM (0.50) | ATMHCAR2EPHX2MAPTRAB9A | |
| SCHEMBL18364899 | 0.90 | ATM (0.55) | ATMHCAR2EPHX2MAPTRAB9A | |
| SCHEMBL18364149 | 0.89 | HCAR2 (0.45) | ATMHCAR2EPHX2MAPTRAB9A | |
| SCHEMBL18364370 | 0.86 | ATM (0.50) | ATMHCAR2EPHX2MAPTRAB9A | |
| SCHEMBL18364766 | 0.83 | ATM (0.48) | ATMHCAR2EPHX2MAPTRAB9A | |
| SCHEMBL17081963 | 0.83 | TSHR (0.56) | EPHX2EPHX1ACHEZDHHC20ZDHHC2 | |
| SCHEMBL18364430 | 0.82 | EPHX1 (0.51) | ATMHCAR2EPHX2MAPTRAB9A | |
| SCHEMBL18364366 | 0.81 | ATM (0.47) | ATMHCAR2EPHX2MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170008835-A1 | FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE | Nguyen, Mark Quang (US) | 2017-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170008835-A1 | FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE | FH, FPGS, APC | ATM 4406/4885HCAR2 290/4885EPHX2 2144/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.